{
    "pattern": {
        "classification": "Hepatocellular",
        "R_ratio": 15.9,
        "keyLabs": [
            {
                "label": "ALT",
                "value": "1650 U/L",
                "note": "↑↑↑"
            },
            {
                "label": "AST",
                "value": "2100 U/L",
                "note": "↑↑↑"
            },
            {
                "label": "ALP",
                "value": "350 U/L",
                "note": "↑↑"
            },
            {
                "label": "Total Bilirubin",
                "value": "12.5 mg/dL",
                "note": "↑↑↑"
            },
            {
                "label": "INR",
                "value": "1",
                "note": "Normal"
            }
        ],
        "clinicalFeatures": [
            "Severe fatigue",
            "Jaundice",
            "Epigastric pain",
            "Confusion",
            "Oral mucosal ulcerations"
        ]
    },
    "causality": {
        "primaryDrug": "Trimethoprim-Sulfamethoxazole",
        "contributingFactors": [
            "Methotrexate use",
            "Age 63",
            "Chronic kidney disease",
            "Alcohol use (1-2 beers/day)"
        ],
        "mechanisticRationale": [
            "TMP-SMX can increase free methotrexate levels.",
            "TMP-SMX can impair folate metabolism.",
            "Combined toxicity potentiates hepatocellular necrosis.",
            "Idiosyncratic hepatocellular DILI is suggested by the timeline."
        ]
    },
    "severity": {
        "features": [
            "Hepatic Encephalopathy (confusion, asterixis)",
            "Coagulopathy (INR 1, borderline but labs in setting of severe injury)",
            "Marked jaundice (Total Bilirubin 12.5 mg/dL)",
            "Very high transaminases (ALT 1650 U/L, AST 2100 U/L)"
        ],
        "prognosis": "Severe, meets criteria for acute liver failure."
    },
    "management": {
        "immediateActions": [
            "Withdraw Methotrexate",
            "Withdraw Trimethoprim-Sulfamethoxazole",
            "Initiate N-acetylcysteine",
            "Admit to ICU",
            "Aggressive supportive care"
        ],
        "consults": [
            "Hepatology",
            "Gastroenterology",
            "Hematology"
        ],
        "monitoringPlan": [
            "STAT labs including CBC, CMP, coagulation panel, Methotrexate level",
            "Frequent neurological checks",
            "Vital signs monitoring",
            "Liver function tests (ALT, AST, Bilirubin, ALP) monitoring",
            "Renal function monitoring"
        ]
    },
    "easl_result" : {
        "diagnosis" : "<paragraph explain the diagnosis from EASL result>",
        "references" : [
            {
                "source" : "<mention source name>",
                "supporting_text" : "<relevant text from the source>"
            }
        ]
    }
}